Production Planning for Pharmaceutical Companies Under Non-Compliance Risk
Operations Research Proceedings, pp. 545.0-550, 2011.
This paper addresses a production planning setting for pharmaceutical companies under the risk of failing quality inspections that are undertaken by the regulatory authorities to ensure good manufacturing practices. A staged decision model is proposed where the regulatory authority is considered an adversary with limited inspection budget...More
Full Text (Upload PDF)
PPT (Upload PPT)